UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Journal of translational medicine, 2011-11, Vol.9 (1), p.204-204, Article 204

2011

Volltextzugriff (PDF)

Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?

Cancers, 2023-10, Vol.15 (21), p.5189

2023

Volltextzugriff (PDF)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer

Cancers, 2023-03, Vol.15 (5), p.1597

2023

Volltextzugriff (PDF)

The Renewal of Cancer Immunotherapy

Vaccines (Basel), 2023-03, Vol.11 (3), p.592

2023

Volltextzugriff (PDF)

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

Journal of translational medicine, 2022-04, Vol.20 (1), p.159-159, Article 159

2022

Volltextzugriff (PDF)

Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors

Frontiers in immunology, 2019-10, Vol.10, p.2353-2353

2019

Volltextzugriff (PDF)

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma

Frontiers in immunology, 2021-10, Vol.12, p.778459-778459

2021

Volltextzugriff (PDF)

Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis

Therapeutic advances in gastroenterology, 2021, Vol.14, p.1756284821989559

2021

Volltextzugriff (PDF)

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Vaccines (Basel), 2022-06, Vol.10 (7), p.999

2022

Volltextzugriff (PDF)

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Journal of translational medicine, 2004-07, Vol.2 (1), p.27-27

2004

Volltextzugriff (PDF)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

Journal of translational medicine, 2006-08, Vol.4 (1), p.36-36, Article 36

2006

Volltextzugriff (PDF)

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

Clinical & developmental immunology, 2010-01, Vol.2010 (1), p.504979

2010

Volltextzugriff (PDF)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

Journal of translational medicine, 2010-06, Vol.8 (1), p.52-52, Article 52

2010

Volltextzugriff (PDF)

In vitro CAR-T cell killing: validation of the potency assay

Cancer Immunology, Immunotherapy : CII, 2024-07, Vol.73 (9), p.168, Article 168

2024

Volltextzugriff (PDF)

Convegno nazionale RE_CYCLING Social Housing

Techne (Florence, Italy : 2011), 2014-01, Vol.7, p.235

Ridolfi, Laura

2014

Volltextzugriff (PDF)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T Therapy against Breast Cancer

Cancers, 2023-03, Vol.15 (5)

2023

Volltextzugriff (PDF)

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy

Cancer Immunology, Immunotherapy, 2012-01, Vol.61 (1), p.41-48

2012

Volltextzugriff (PDF)

Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14025-e14025

2023

Volltextzugriff (PDF)

Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series

Journal of neuro-oncology, 2023-08, Vol.164 (1), p.55-64

2023

Volltextzugriff (PDF)

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Journal of neuro-oncology, 2014-05, Vol.118 (1), p.109-116

2014

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(112)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer

The Renewal of Cancer Immunotherapy

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study

GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Evaluation of in vivo labelled dendritic cell migration in cancer patients

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

In vitro CAR-T cell killing: validation of the potency assay

Convegno nazionale RE_CYCLING Social Housing

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T Therapy against Breast Cancer

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy

Results from the first step of a phase II study of vaccination with autologous dendritic cells loaded with autologous tumour homogenate in glioblastoma

Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series

The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population‐based investigation

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup

Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products

Suchergebnisse filtern